Correlation Between Lipocine and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Lipocine and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lipocine and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lipocine and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Lipocine and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lipocine with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lipocine and Apogee Therapeutics,.

Diversification Opportunities for Lipocine and Apogee Therapeutics,

0.37

Correlation Coefficient

Lipocine  Apogee Therapeutics,

Weak diversification

The 3 months correlation between Lipocine and Apogee is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Lipocine and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Lipocine is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lipocine are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Lipocine i.e., Lipocine and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Lipocine and Apogee Therapeutics,

Given the investment horizon of 90 days Lipocine is expected to generate 1.42 times more return on investment than Apogee Therapeutics,. However, Lipocine is 1.42 times more volatile than Apogee Therapeutics, Common. It trades about 0.1 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about -0.02 per unit of risk. If you would invest  365.00  in Lipocine on September 3, 2024 and sell it today you would earn a total of  89.00  from holding Lipocine or generate 24.38% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Lipocine  vs.  Apogee Therapeutics, Common

Lipocine

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Lipocine are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very uncertain fundamental indicators, Lipocine displayed solid returns over the last few months and may actually be approaching a breakup point.

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Lipocine and Apogee Therapeutics,

The main advantage of trading using opposite Lipocine and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lipocine position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Lipocine and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.